We hypothesized that CXCL13 expressed in T cells and CD79A and IGLL5 expressed in B cells could affect the expression of LHFPL2 gene through the CD45 signaling pathway, acting on macrophages, thus jointly playing a role in tumor regulation. The gene discussed is LHFPL2; the disease is neoplasm.